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ABSTRACT
In the human genome,  10% of the genes are
arranged head to head so that their transcription
start sites reside within <1kbp on opposite
strands. In this configuration, a bidirectional
promoter generally drives expression of the two
genes. How bidirectional expression is performed
from these particular promoters constitutes a
puzzling question. Here, by a combination of in
silico and biochemical approaches, we demonstrate
that hStaf/ZNF143 is involved in controlling expres-
sion from a subset of divergent gene pairs. The
binding sites for hStaf/ZNF143 (SBS) are over-
represented in bidirectional versus unidirectional
promoters. Chromatin immunoprecipitation assays
with a significant set of bidirectional promoters con-
taining putative SBS revealed that 93% of them are
associated with hStaf/ZNF143. Expression of dual
reporter genes directed by bidirectional promoters
are dependent on the SBS integrity and requires
hStaf/ZNF143. Furthermore, in some cases, func-
tional SBS are located in bidirectional promoters of
gene pairs encoding a noncoding RNA and a protein
gene. Remarkably, hStaf/ZNF143 per se exhibits
an inherently bidirectional transcription activity, and
together our data provide the demonstration that
hStaf/ZNF143 is indeed a transcription factor con-
trolling the expression of divergent protein–protein
and protein–non-coding RNA gene pairs.
INTRODUCTION
Despite the vast genomic space, a substantial fraction of
human genes (11%) are arranged as bidirectional gene
pairs in a head to head, divergent fashion and controlled
by bidirectional promoters (1,2). A bidirectional promoter
was deﬁned as an intergenic region containing <1kb of
DNA which is ﬂanked by the transcription start sites
(TSS) of two genes in opposite directions (1,2). Thus the
closely located bidirectional pairs are overrepresented in
the human genome and this abundance has been observed
across several mammalian genomes (3). For a vast
majority of human bidirectional promoters where the
associated genes have mammalian orthologs the bidirec-
tional arrangement is conserved suggesting that it is func-
tionally important (1,2). Indeed, the expression pattern of
divergent gene pairs are more correlated than those of
randomly paired genes (2). Most of the bidirectional pro-
moters lack TATA element, are GC rich and exhibit
enriched colocalization with CpG islands (2,4).
Bidirectional promoters display also a mirror sequence
composition with an overrepresentation of G and T on
one side of the promoter, and C and A on the other, on
the genomic plus strand (5). Divergent promoters are
enriched in binding site consensus sequences of a small
group of transcription factors including GABPA/NRF2,
NRF1, NFY and YY1 while the majority of known ver-
tebrate binding motifs are underrepresented in bidirection-
al promoters (6). Further study has shown that the
GABPA/NRF2 factor is involved in the regulation of
transcription from divergent gene pairs (7). The work
described in this article establishes that the human tran-
scription factor Staf (hStaf, also called ZNF143) acts also
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promoters. Staf, originally identiﬁed in Xenopus laevis as
the transcription activator of the tRNA
Sec gene, also
controls expression of snRNA and snRNA-type genes
(8–11). Seven contigous zinc ﬁngers of the C2–H2 type
contain the Staf DNA binding domain and only zinc
ﬁngers 1–6 establish base-speciﬁc contacts with 18bp in
Staf–DNA complexes (12–14). Furthermore, hStaf/
ZNF143 has been reported to regulate transcription
of the SCARNA2 gene and of 10 protein coding genes
(15–17 and references therein). Lastly, a genome-wide
analysis led us to identify 1175 hStaf/ZNF143 binding
sites (SBS) distributed in 938 promoters of mammalian
protein genes, strongly suggesting that hStaf/ZNF143 is
involved in the transcriptional regulation of a very large
number of protein coding genes (18). In the present study,
we conducted bioinformatic and biochemical analysis
at the whole genome scale which demonstrated that func-
tional SBS are overrepresented in bidirectional compared
to unidirectional promoters. Chromatin immunopre-
cipitation assays (ChIP) on 100 representative bidirection-
al promoters containing putative SBS revealed that 93%
of them are associated with hStaf/ZNF143. Using a com-
bination of luciferase, RTase assays, hStaf/ZNF143
overexpression and silencing, we demontrated that
hStaf/ZNF143 is clearly involved in the bidirectional
expression directed by the promoters of protein–protein
and protein–non-coding RNA gene pairs. Furthermore
we also showed that, in dual reporter genes, the sole
presence of an SBS isolated from unidirectional promoters
was sufﬁcient to direct bidirectional transcription,
demonstrating that hStaf/ZNF143 per se exibits an
inherent bidirectional activity.
MATERIALS AND METHODS
Identiﬁcation of bidirectional gene pairs
Bidirectional gene pairs were identiﬁed by skimming
through the gene annotation set constituted by Genomic
Context database (GeCo) (Y.-N. Anno et al., manuscript
in preparation) and extracting all pairs of genes in inverted
orientations separated by <1kbp, regardless of their gene
type. The Genomic Context database is related to human
genome NCBI build 36 (hg18) and was built by computing
‘refGene’ (proteins), ‘rnaGene’ (snRNA, snoRNA, tRNA,
rRNA, scaRNA), kgXref tables from the University of
Santa Cruz California (UCSC, www.genome.ucsc.edu),
‘mirna’, ‘mirna_literature_references’, ‘mirna_mature’
and ‘literature_references’ tables from Sanger Institute
and piRNA’s ﬁle from the piRNAdatabank. It was imple-
mented locally in a high-speed DB2 architecture called
Biological Integration and Retrieval of Data (BIRD),
allowing to quickly address the whole gene set (19).
For each bidirectional promoter, 10 randomly chosen
unidirectional promoters of the same size were ex-
tracted from GeCo, assessing that a gene with no other
gene in the vicinity of its TSS (1kbp) is a unidirectional
promoter.
Sequence analysis and identiﬁcation of potential SBS in
promoters
Prediction of Staf binding sites in bidirectional and uni-
directional promoters was performed with a position-
speciﬁc scoring matrix (PSSM) built using 347 experimen-
tally validated binding sites (18). Matrix generation and
scan of sequences were done using the Genomatix suite,
with MatDeﬁne and MatInspector programs (20), respect-
ively. Signiﬁcant overrepresentation of SBS in bidirection-
al promoters was evaluated using the khi
2 test for two
proportions, with alpha=0.05 and 1 degree of freedom
(df). The test was repeated 10 times on corresponding
random sets (Supplementary Table S1) and assessed in
100% of the cases a signiﬁcantly higher rate of predicted
SBS in bidirectional promoters.
Reporter constructs
Thirteen human bidirectional promoters (extended
intergenes EI1–EI13) ranging from 229 to 751bp were
PCR ampliﬁed from human genomic DNA (list of
primers and chromosomal localization available as
Supplementary Table S2) and cloned into pGEMTeasy
(Promega). BamHI and SacI sites were included in the
forward and reverse primers, respectively, used for PCR
ampliﬁcation of EI11 and EI12. KpnI sites were included
in the primers used in EI13 ampliﬁcation. The dual
luciferase reporters constructs containing EI1–EI10 were
obtained as follows. EcoRI fragments isolated from
pGEMTeasy constructs containing EI1–EI10 were
subcloned into EcoRI-cut pFRLN50 dual luciferase
reporter vector generated by insertion of the NcoI linker
CATGGGAGCTCGAATTCGAGCTC in the NcoI site
of the pFRL vector (21).The luciferase reporter constructs
containing the EI11 and EI12 fragments were generated
by subcloning the BamHI-SacI and NotI-SacI fragments
isolated from pGEMTeasy-EI11 and EI12 into BamHI-
SacI and NotI-SacI cut pFlashI luciferase reporter
vector (SynapSys), respectively. The KpnI fragment
isolated from pGEMTeasy-EI13 was subcloned in KpnI-
cleaved pU6/Hae/RA.2/EcoRV construct (11,22). The re-
sulting BamHI-Sac1 fragment containing EI13, followed
by a 137bp spacer derived from the b-globin gene, was
subcloned into BamHI-SacI cut pFlashI luciferase
reporter vector. PCR primers were designed so that the
PCR products containing the EI1–EI11 and EI13 pro-
moters do not contain the AUG initiation codon of the
endogenous gene. Instead, translation initiation is ensured
by the AUG of the luciferase reporter genes. For the
luciferase construct containing the EI12 birectional
promoter, the endogenous AUG of the C19orf6 gene
was in frame with the AUG of the ﬁreﬂy luciferase.
MaxiU6 genes were created by inserting the GACCTCG
AGGCGGTTC sequence at position 87 of the wt U6. In
all mutant versions of the SBS, the NNCCCR sequence (N
standing for any nucleotide, R for A or G) at positions 1–6
of the SBS was replaced by GGTTTC. The dual luciferase
vector with part of the BUB1B promoter containing two
SBS and the associated ACTACAA motif was prepared
as in Myslinski et al. (16). The 271bp DNA fragment
(Ch15: 38 240 250–38 240 520, in hg18) was ampliﬁed
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EcoRI-cut pFRLN50. All mutants were generated with
the QuickChange II XL site-directed mutagenesis kit
(Stratagene) and veriﬁed by DNA sequencing.
ChIP assay and semi-quantitative PCR analysis
The ChIP procedure and the PCR analysis was performed
as described in Myslinski et al. (18) using a rabbit poly-
clonal antibody against a C-terminal epitope of Staf. For
the negative control, we used the PP1–PP4 primer pairs
hybridizing to unique regions located at 2.4, 2.1, 6.5 and
2.5kbp upstream of the tRNASec, U4 ATAC, GAPDH
and BUB1B genes and generating PCR products of 235,
211, 174, 226bp, respectively. The primer sequences used
in this study are available on request.
Transfection and bidirectional promoter activity assay
HeLa cells (5 10
3cells/well in 96-well plates) were
cotransfected using Lipofectamine 2000 with 200ng of
each experimental luciferase construct (containing wt or
mutated EI1–EI13 promoters) and 100ng of the pCH110
internal control plasmid. After 24h, cells lysates were
prepared with passive lysis buffer (Promega) and assayed
for b-galactosidase and luciferase activities. The ﬁreﬂy and
Renilla luciferase assays (promoters EI1–EI10) were per-
formed using the dual-luciferase TM Reporter assay
system (Promega) on a GloMax
TM
96 Plate Luminometer
(Promega). The ﬁreﬂy luciferase assay (promoters EI11–
EI13) was performed using the Luciferase assay system
(Promega). The luciferase activities were normalized to
the b-galactosidase activity. Each transfection experiment
and luciferase assay were done at least in triplicate. For
U6 snRNA and RPPH1 (H1RNA) gene expression
analysis, HeLa cells (9 10
5cells) were cotransfected
using Lipofectamine 2000 with 8.4mg of wt or mutant
luciferase constructs containing the EI11 to EI13 pro-
moters with 600ng of maxi5S RNA as internal standard.
Cells were collected after 48h and total RNA was ex-
tracted using TRIREAGENT (Euromedex). Total RNA
was analyzed by primer extension of two labeled oligo-
nucleotides, one complementary to positions +88/+104
of the maxiU6 (human wt U6 gene numbering) and the
other to positions+112/+129 of the maxi5S. The extended
products were separated on a 6% denaturing gel and
quantitated with a Fuji Bioimage Analyzer. The yield of
extended maxiU6 was normalized to that of extended
maxi5S. Each transfection experiment and reverse tran-
scriptase assay were done at least in triplicate. H1 RNA
gene expression from the EI13 promoter was monitored as
described in Myslinski et al. (11).
Transfection of siRNA, overexpression, reverse
transcription and RT–qPCR
The hStaf/ZNF143-speciﬁc siRNAs GCUGGAAGAUG
GUACCACAGCUUAU (siRNA1), GGGCAUUUGCC
AGUGCAACAAAUUA (siRNA2), GGAACGCACUC
UGUUGCUAUGGUUA (siRNA3) or control-siRNA
(Invitrogen) were transfected into HeLa cells using
Lipofectamine 2000 according to the maufacturer’s in-
structions (Invitrogen). To obtain hStaf/ZNF143
overexpression, HeLa cells (5 10
5cells) were transfected
with Lipofectamine 2000. Cells received 3mgo f
pcDNA3.1-hStaf/ZNF143 (10) with 500ng of pCH110
as internal control. The total amount of DNA was kept
constant (4mg) with carrier DNA. Total RNA was
isolated using TRIREAGENT (Euromedex) from cells
harvested 48h (overexpression experiment) or 72h
(siRNA transfection) post transfection, treated by
RNase-free DNase and reverse transcribed using oligo
(N)9 primer. cDNA was ampliﬁed by qPCR with gene
speciﬁc primers on a Stratagene Mx3005P PCR system
(Agilent Technologies) using EvaGreen qPCR Mix Plus
(Euromedex). We used Primer3 software (http://frodo
.wi.mit.edu/primer3/) to design primers so that the ﬁnal
amplicon was 100–150bp. The primer sequences used in
this study are available on request. All reactions were
carried out in triplicate. Relative gene expression was
calculated using the Ct method following the manufac-
turer’s instructions.
RESULTS
Promoter size and genes associated in bidirectional
promoters
We extracted from the Genomic Context database (GeCo)
pairs of human genes that are the closest neighbors on
opposite strands and with their TSS separated by
<1kbp (‘Materials and Methods’ section). In this
search, we included only those genes whose transcripts
were not predicted to overlap at the 50-ends. As deﬁned
by Trinklein et al. (2), we considered the region between
the two TSS as a putative bidirectional promoter.
Therefore, the constituted set contained 839 bidirectional
promoters and 1678 genes (Supplementary Table S3, part
1). Different interesting features regarding the size of the
bidirectional promoters, distribution of the sizes and the
length of the genes in the divergent gene pairs arose from
our study. First, considering the size of the bidirectional
promoters, Figure 1 shows the number of bidirectional
promoters with a deﬁnite length plotted versus their
length. We found a bias toward a small size: 83% of the
promoters harbor a size <500bp. Second, the size distri-
bution of the bidirectional promoters is not uniform.
Indeed different pools are present with preferential sizes
of 80–140, 240–280 and 360–420bp corresponding to 25,
10 and 7% of the total bidirectional promoter set, respect-
ively. Third, a bias toward small size genes associated to
divergent promoters was observed compared to unidirec-
tional promoters: 40.1 versus 112.8kbp (Supplementary
Table S3, part 2). The bidirectional promoter set is
constituted at 95% (801 out of the 839) of protein
coding gene pairs (c–c gene pairs). The remainder is
distributed into two small groups: 26 combine a non-
coding (nc) RNA gene with a protein coding partner
(nc–c gene pairs), and 12 contain ncRNA genes only
(nc–nc gene pairs). All members of the nc–nc subgroup
are entirely constituted of two tRNA genes but tRNA
genes were also identiﬁed in 17 of the nc–c pairs. The
ncRNA genes present in the other nine nc–c gene pairs
are: MRP-RNA, H1-RNA, SRP-RNA, 7SK RNA,
3118 Nucleic Acids Research, 2011,Vol.39, No. 8scaRNA17 (U91), U13 snoRNA, U6.2 snRNA, U6.9
snRNA and U12 snRNA (Supplementary Table S3, part
1). Thus, the closely located divergent gene pairs and the
associated bidirectional promoters harbor a biased small
size, suggesting a putative functional importance of this
particular feature.
Sequence analysis and staf binding site identiﬁcation in
bidirectional promoters
The hStaf/ZNF143 Staf binding site (SBS) consists of a
18bp sequence with a highly conserved consensus
sequence CCCR at positions 3–6, a highly conserved C
at position 12 and a more degenerate sequence at positions
1–2, 7–11 and 13–18 (9,12,18). The strategy to identify
SBS in bidirectional promoters was the following. We col-
lected a pool of 347 binding sites experimentally validated
by ChIP (18) and converted them into a position-speciﬁc
scoring matrix (PSSM) using MatDeﬁne programs of the
Genomatix suite (20) (Supplementary Figure S1). We then
used MatInspector to search matrix matches in the se-
quences of intergenes and in the ﬁrst 400bp of the
transcribed sequences of two genes partners. The search
was extended to the ﬁrst 400bp of the genes because it is
well established that the ﬁrst exon and 50 part of the ﬁrst
intron of genes contain transcription factors binding sites
(TFBS) (23). With an optimal cutoff score of 0.82, the
search identiﬁed 601 SBS above the cutoff and which
are distributed in 392 potential bidirectional promoters
(392 out of 839: 46.7% of the bidirectional promoters)
(Figure 2A, Supplementary Tables S3 and S4). Among
these 392 pairs, 11 combine a ncRNA gene with a protein
coding partner (nc–c gene pairs) and two combine two
ncRNA genes (nc–nc gene pairs) (Figure 2A and
Supplementary Table S5). The two nc–nc gene pairs
contain each two tRNA genes, tRNA
Gly-TCC–
tRNA
Trp-CCA and tRNA
Arg-TCG–tRNA
Arg-CCT. Among
the 11 nc–c gene pairs, six of them contain a tRNA gene
and in the other ﬁve nc–c gene pairs, the ncRNA gene
partner is the RNase MRP RNA, RNase P RNA
(H1RNA), SRP-RNA (RNA 7SL1), snRNAU6.2 and
snRNAU6.9 (Supplementary Table S5).
Among 126 (21%) of the 601 identiﬁed SBS, inspection
of sequences adjacent to the identiﬁed SBS revealed the
presence, immediately upstream of the SBS, of the 9-bp
RRACTAYRN motif or a one bp variant (Figure 2B).
Among the 392 promoters identiﬁed as containing an
SBS, 203 (51.8%) harbored at least one SBS in the
intergene, the percentage being 24.2% (203/839) when
considering the whole set of bididirectional promoters at
the onset of this study (Supplementary Table S3, part 1).
A control set was generated by random extraction from
unidirectional promoters of a bp number equivalent to the
total bp number in the intergenic region of the 839 bidir-
ectional promoters. The search of SBS in this and nine
other different control sets showed that 10% of unidirec-
tional promoters contain at least one SBS.
Altogether, these results indicate that hStaf/ZNF143
binding sites are present in at least 46.7% of the bidirec-
tional promoters with a 2.4-fold enrichment compared to
unidirectional promoters.
In vivo occupancy of bidirectional promoters by hStaf/
ZNF143
To determine whether hStaf/ZNF143 is indeed associated
in vivo with the bidirectional promoters identiﬁed as
containing putative SBS, a chromatin immunopre-
cipitation assay was performed in HeLa cells. We
examined 186 putative SBS with scores ranging from
0.82 to 0.99 (listed in Supplementary Table S6, scores in
Supplementary Table S4), contained in 100 (25.5%) of the
392 promoters identiﬁed as containing SBS. The 100
selected promoters correspond to 87 pairs of protein
coding genes only and to the whole set of c–nc (11 pairs)
and nc–nc gene pairs (2 pairs). The 87 pairs were extracted
with a random choice from the bidirectional promoter
set (Supplementary Table S4). After immunoprecipitation
with an antibody speciﬁcally recognizing hStaf/ZNF143,
enrichment of the promoters was monitored by
Figure 1. Features of bidirectional promoter sizes in the human genome. The length of the bidirectional promoter in base pair is plotted versus the
frequency of its occurrence (promoter number for a 10bp interval). Dotted line indicates the position of the promoters pools.
Nucleic Acids Research,2011, Vol.39, No. 8 3119semi-quantitative PCR ampliﬁcation with primers amp-
lifying the regions surrounding the putative SBS. The spe-
ciﬁcity of the ChIP reaction was monitored by PCR
ampliﬁcation of four promoters recognized by hStaf/
ZNF143 (Figure 2C, tRNA
Sec, synaptobrevin-like1,
aldehyde reductase and t-complex polypeptide 1 pro-
moters as positive controls) and four DNA fragments
which do not contain any hStaf/ZNF143 binding site
A
B
CD
F E
Figure 2. Characterization of bidirectional promoters that are target for hStaf/ZNF143 and detection of promoter occupancy in vivo by chromatin
immunoprecipitation (ChiP). (A) Outline showing identiﬁcation of the target promoters. The results of the ChIP and PCR assays performed on 100
promoters (87 protein coding pairs, 11 protein coding–nc RNA pairs and two noncoding–noncoding RNA pairs) are indicated. (B) SBS motif
analysis with sequence logos depicting nucleotide distribution in the SBS (left panel) and in the SBS with the 50-associated submotif (right panel)
(C–F). Binding of the endogenous hStaf/ZNF143 to genomic sites in HeLa cells was analyzed by ChIP. Genomic DNA fragments, recovered from
input material or immunoprecipitated with hStaf/ZNF143 antibody or no-antibody, were subjected to semi-quantitative PCR ampliﬁcation in the
presence of (a
32P)-dCTP with speciﬁc primer pairs. Lanes 1,2 and 3,4: serial dilutions of DNA immunoprecipitated with anti-hStaf/ZNF143 or
no-antibody (no Ab), respectively. Lanes 5–7: serial dilutions of input material. Lane 8 (NC, negative control): PCR lacking the chromatin DNA
template. Positive (C) and negative (D) controls for ChIP assays. Promoters used are indicated on the right of panel C. PCR products generated with
the PP1–PP4 primer pairs originate from unique regions 2.4, 2.1, 6.5 and 2.5kbp upstream of the tRNA
Sec, U4 ATAC, GAPDH and BUB1B genes,
respectively. Typical positive and three negative results obtained from bidirectional promoter regions are depicted in E and F, respectively.
Bidirectional promoters are indicated by gene names.
3120 Nucleic Acids Research, 2011,Vol.39, No. 8(Figure 2D, negative controls). Each DNA sequence was
tested with each of the three templates obtained from anti-
hStaf/ZNF143, control ChIP and input chromatin. We
tested two dilutions of DNA isolated with (Figure 2C–F,
lanes 1 and 2; Supplementary Figure S2A) or without
antibody (Figure 2C–F, lanes 3 and 4; Supplementary
Figure S2A). In addition, a serial dilution of the input
material was analyzed to demonstrate that the PCR
was quantitative within a linear range of ampliﬁcation
(Figure 2C–F, lanes 5–7; Supplementary Figure S2A).
As expected, the positive controls yielded a signal of in-
tensity higher with anti-hStaf/ZNF143 than in the
no-antibody control (Figure 2C, compare lanes 1,2 and
3,4). In contrast, no speciﬁc signal could be obtained
with the primer pairs PP1 to PP4 amplifying DNA se-
quences lying several kbp upstream of the tRNA
Sec,U 4
ATAC, GAPDH and BUB1B genes because these remote
regions were not expected to interact with hStaf/ZNF143
(compare lanes 1,2 and 3,4 in Figure 2D). Among the 87
PCR ampliﬁcations involving promoters of c–c gene pairs
(Figure 2E and F, and Supplementary Figure S2A), three
of them (I101, I125 and I841; Figure 2F) were close to
background level but the remaining 84 provided clear
positive signals (Figure 2E and Supplementary
Figure S2A; Table S6). These experiments showed that
97% (84 out of 87) of the bidirectional promoters of the
c–c gene pairs tested did contain genuine hStaf/ZNF143
binding sites. In an additional control, we ampliﬁed from
ChIP samples a DNA region corresponding to bidirec-
tional promoters of c–c gene pairs identiﬁed in silico but
lacking SBS. Of the 10 promoters that were tested,
none provided positive ampliﬁcation (Supplementary
Figure S2B), suggesting that the hStaf/ZNF143 sequence
is necessary for protein binding in vivo. More contrasted
results were obtained with the PCR ampliﬁcations of nc–nc
and nc–c gene pair promoters. Among the 13 that
were tested, only 9 (69%) provided positive ampliﬁcation:
LTA4H-tRNA
Asp-GTC, PARP2-RPPH1, PRMT5-
tRNA
Arg-ACG, RPS29-SRP RNA, POLG-tRNA
Arg-TCG,
PSMB3-tRNA
AsnGTT, MED16-snRNAU6.9, C19orf6-
snRNAU6.2, SLC27A4-tRNA
Arg-TCT (Figure 2E;
Supplementary Figure S2A and Table S6). This will be
further discussed.
Taken together, these results demonstrate the robutness
of the computational screens and reveal the very high
prevalence of bona ﬁde direct targets of the hStaf/
ZNF143 transcription factor in bidirectional promoters
of c–c gene pairs.
Functional activity of the hStaf/ZNF143 binding site in
bidirectional expression of protein gene pairs
We assessed the ability of 10 of the bidirectional pro-
moters (associated with hStaf/ZNF143) to initiate tran-
scription from both directions. These were EI1 to EI10
and are constituted of pairs of protein coding genes only
(Table 1 and Supplementary Table S6). DNA fragments
containing the full intergenic region lying between the TSS
and parts of the ﬁrst exon of the protein genes were
inserted into a dual reporter vector (21) in which the tran-
scription activities in the two opposite directions could be
tested simultaneously via the readout of the ﬁreﬂy and
Renilla luciferases (Table 1, Figure 3 and Supplementary
Figure S3). HeLa cells were transiently transfected with
the different constructs and the luciferase activities of
the resulting cells extracts was measured. Analysis of the
ﬁreﬂy and Renilla luciferase activities, normalized to that
of the b-galactosidase control (Figure 3 and
Supplementary Figure S3), showed that all the tested con-
structs bore bidirectional activity. The transcription
activity depending on the promoter tested was from 9.2-
to 100-fold in the Renilla, and from 6- to 160-fold in the
ﬁreﬂy luciferase direction that of the promoter-less empty
Table 1. Characteristics of the 13 bidirectional promoters analyzed and effects of the SBS substitutions on the direction of transcription
EIn Intergene (I) Genes in pair SBS number
in EIn
SBS mutants
number in EIn
Transcriptional effect
of SBS mutation
(in order of SBS in EIn)
EI1 I124 C11orf10–FEN1 2 2 b–b
EI2 I202 KNTC1–RSRC2 1 1 b
EI3 I252 C14orf133–AHSA1 3 3 b–b–u
d (AHSA1)
EI4 I298 TMEM186–PMM2 3 2 b–b
EI5 I512 TRAK2–STRADB 2 2 u
i (STRADB)–b
EI6 I562 ZMAT5–UCRC 4 3 u
i (ZMAT5)–b–b
EI7 I659 COL4A3BP–POLK 2 2 b*–b
EI8 I758 DOCK4–ZNF277 1 1 b
EI9 I775 NUDCD1–ENY2 4 4 u
d (ENY2)–u
d (ENY2)–b–b
EI10 I797 ZNF189–MRPL50 2 2 b–b
EI11 I418 MED16–U6.9 3 2 b**–b**
EI13 I419 C19orf6–U6.2 2 2 b**–b**
EI13 I221 PARP2–RPPH1 1 1 b
EIn: name of the extended intergene. The intergene name refers to Supplementary Table S3. The numbers of SBS identiﬁed and SBS mutated in the
intergene are mentioned. The effect of SBS substitution on the direction of transcription is indicated.
b, bidirectional effect with decrease in both directions.
u
d (XXX), unidirectional effect with decrease in the direction of gene in parenthesis.
u
i (XXX), unidirectional effect with increase in the direction of gene in parenthesis.
b*, decreased and increased efﬁciencies in COL4A3BP and POLK directions, respectively.
b**, decreased and increased efﬁciencies in protein gene and U6 directions, respectively.
Nucleic Acids Research,2011, Vol.39, No. 8 3121vector (Figure 3 and Supplementary Figure S3). The in
silico data found that the fragments inserted in the dual
luciferase reporter vector contain 1–3 SBS, with 17 SBS in
total (Supplementary Table S4). However, visual inspec-
tion of the sequence revealed the presence of seven add-
itional putative SBS, in fragments EI1, EI3, E16, EI9 and
E110, that were unlisted by the bioinformatic screen (SBS
with a score below 0.82; SBS1 in EI1, SBS1 and SBS2 in
EI3, SBS4 in EI6, SBS3 and SBS4 in EI9 and SBS2 in
EI10; Supplementary Figure S3). To determine whether
the 24 SBS (17+7) do play a role in bidirectional tran-
scription, the effect of substitutions at positions 1–6 in the
SBS core sequence NNCCCR was tested on expression of
the reporter gene. Such substitutions were known to com-
pletely abolish formation of the DNA–protein complex
(9,16). Twenty-two of the 24 SBS identiﬁed in the 10 pro-
moters were mutated singly, and simultaneous mutations
of SBS1 and SBS2 were engineered in EI1, EI4 and EI7
where they reside in the same promoter (Supplementary
Figure S3). All single mutations had an effect on tran-
scription efﬁciency. Five substituted SBS altered tran-
scription unidirectionally whereas it was affected
bidirectionally for 17 of them (77%) (Supplementary
Figure S3 and Table 1). In the 10 promoters tested, at
least one SBS was involved in the bidirectional control of
transcription. For 16 of the 17 mutants with
Extended
intergene
Genes in 
pair
intergene SBS  position strand  score 
EI4 TMEM186-
PMM2
I298 SBS1  89-106  -  0.909 
268 bp    201 bp  SBS2  137-154  +  0.846 
    SBS3  171-187  +  0.871 
1-GGCCCCACCACCTGCTGCCGGAAGTAAATCCCACCGGCCCCCGGAACCCCTAAGAGCGCATGC
TCGAATGTACAAGGCGGGCGTGATCTGCGTTGCACCCTGGGAGTTGCGGTCCAGGAATCGTGGCTG
CCGCTACTCCCAGGCGTTATGGGAACGGAGTCCCCTCCTCTTCCCGACGTGCCCTGCGACTCAGCG
GCCGAACCCGGAAGTTCCGGGCCGAGTTCCTCGTGCCAACGTGTCTTGTAAGGTGCGGCTAGAAAC
TGGGGAC-268
Extended
intergene
Genes in 
pair
intergene SBS  position strand  score 
EI12 C19orf6-
snRNA
U6.2
I419 SBS1  81-98  -  0.912 
523 bp    379 bp  SBS2  288-305  +  0.855 
1-ATCTTCCGCTTTCTCGTCCGGCTGCGGCGCTGCTGACGCTAGCGAGTCGCCACGCCGGGCAAG
AGCGGCCCCCCTGCGCCCGCAGAGAACGCTGGGATGCCAGCGGCGCCCGCGGAGGCCTCACCCCCT
ACCTCGGCCGCTCCAGGGGGCGGGCCTGCATCTGGGCCACCTCTTTTGCATATTGGCACCCACAAT
CCACCGCGGCTATGAGGCCAGTATAAGGCGGTAAAATTACGATAAGATATGGGATTTTACGTGATC
GAAGACATCAAAGTAAGCGTAAGCACGAAAGTTGTTCTGCAACATACCACTGTAGGAAATTATGCT
AAATATGAAACCGACCATAAGTTATCCTAACCAAAAGATGATTTGATTGAAGGGCTTAAAATAGGT
GTGACAGTAACCCTTGAGTCGTGCTCGCTTCGGCAGCACATATACTAAAATTGGAACGATACAGAG
AAGATTAGCATGGCCCCTGCGCAAGGATGACACGCAAATTCGTGAAGCGTTCCATATTTTTGCT-
523
A
B
C
A
B
C
Figure 3. The human TMEM186–PMM2 and C19orf6–snRNAU6.2 intergenic regions act as bidirectional promoters. Mutational analysis of the
promoter identiﬁed the functional importance of the SBS in bidirectional transcription. (A) Characteristics of the extended intergenes EI4 and EI12
(length and name of genes in pair), intergenes (name and length) and SBS (position, orientation and score) are indicated. (B) Sequences of the EI4
(TMEM186–PMM2) and EI12 (C19orf6–snRNAU6.2) regions cloned into the dual and ﬁreﬂy luciferase reporters, respectively. The sequence of the
intergene is underlined, the SBS are highlighted in gray and the U6 gene is in italics. (C) Schematic diagrams of the reporter genes used in the
transfection assays. Mutations ( ) are indicated; the relative transcription activities of the different constructs are indicated, representing either
the luciferase activity/empty vector ratio or the relative activity in the reverse transcription assay for the U6 snRNA expression. The yield of
extended maxiU6 was normalized to that of the extended maxi5S added as the internal standard. Values are mean±SE (error bars), n=3
independent experiments with two replicates/group.
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decreased simultaneouly in both directions, demonstrating
that these SBS are involved in up-regulating both genes
in the pair. Interestingly, in the case of SBS1 in EI7, the
SBS mutation decreased promoter activity in the
COL4A3BP direction and increased it in the POLK direc-
tion (Table 1 and Supplementary Figure S3). In the ﬁve
substitutions leading to unidirectional alteration of tran-
scription, three of them exhibited a decrease: SBS3 in
EI3, AHSA1 direction; SBS1 and SBS2 in EI9, ENY2
direction; and two a unidirectional increase: SBS1 in EI5,
STRADB direction; SBS1 in EI6, ZMAT5 direction
(Table 1 and Supplementary Figure S3). The transcrip-
tional status of the mutants containing two simultaneously
mutated SBS (SBS1 and SBS2 in EI1, EI3 and EI7) essen-
tially recapitulates the effects observed wih the single
mutants. Taken together, these results demonstrate
the functional importance of the hStaf/ZNF143 binding
sites in bidirectional transcription of divergent genes.
The simultaneous presence of two SBS in the promoters
of the C19orf6–U6.2 and MED16–U6.9 gene pairs
down-regulated expression of the U6.2 and U6.9
snRNA genes
The activity of three hStaf/ZNF143-containing bidirec-
tional promoters associating a protein and a ncRNA
gene was tested by transient transfection assays. The
gene pairs were MED16–U6.9, C19orf6–U6.2 and
PARP2–RPPH1. The U6.9 and U6.2 ncRNA genes
encode U6 snRNAs (24), RPPH1 coding for H1 RNA,
the RNA component of the RNase P (from EI11 to
EI13 in Table 1), all three genes being RNA polymerase
III-dependent. To monitor expression from these
promoters, constructs were engineered as follows.
For MED16–U6.9 (EI11) and C19orf6–U6.2 (EI12), we
transfected constructs containing part of the ﬁrst exon of
MED16 or C19orf6, the full intergenic region between the
transcriptional start sites, and the U6.2 or U6.9 genes. In
these constructs, parts of the protein coding genes are
placed in front of the ﬁreﬂy luciferase reporter (EI12
and EI11 in Figure 3 and Supplementary Figure S3),
and a 16bp fragment was inserted into both U6 genes to
distinguish transient expression of the U6 snRNAs from
that of the endogenous genes. For PARP2–RPPH1, the
construct contained part of the ﬁrst exon of PARP2, and
the full intergenic region placed between the luciferase
reporter and a chimeric gene consisting of a 137bp
spacer derived from the b-globin gene followed by an ef-
ﬁcient RNA polymerase III termination site (11,22). After
transfection, expression in the PARP2 direction was
analyzed by the luciferase assay, that toward the RPPH1
gene by RNase protection assay of an antisense RNA
probe normalized to the expression of an a-globin
mRNA included as the internal standard. The results of
these experiments clearly establish that the three pro-
moters possess a bidirectional transcription activity
(Figure 3 and Supplementary Figure S3). To further
address whether the SBS identiﬁed in silico within these
promoters (1–3 SBS in PARP2–RPPH1, C19orf6–U6.2
and MED16–U6.9) are indeed involved in the
bidirectional activity, we examined again the effects of
SBS substitutions on transcription activity. Mutation of
the single SBS in PARP2–RPPH1 decreased expression in
both directions (Supplementary Figure S3). Substitution
of either SBS1 or SBS2 in MED16–U6.9, C19orf6–U6.2
decreased expression in the direction of the protein coding
genes but, surprisingly, increased expression in the U6 dir-
ection. As expected, however, the simultaneous mutations
of both SBS dramatically decreased the promoter activity
in the U6 snRNA direction (Figure 3 and Supplementary
Figure S3). Taken together, our data indicate that the
three PARP2–RPPH1, C19orf6–U6.2 and MED16–U6.9
intergenic regions act as bidirectional promoters and that
the simultaneous presence of two SBS in C19orf6–U6.2
and MED16–U6.9 clearly down-regulated the expression
of the U6.2 and U6.9 genes.
A DNA fragment containing an SBS, with or without the
associated RRACTACAN motif, is sufﬁcient for
bidirectional promoter activity
Having shown that hStaf/ZNF143 binding and bidirec-
tional transcription activity are correlated, we asked
whether an SBS-containing DNA fragment isolated from
a promoter driving unidirectional transcription is sufﬁ-
cient to lead to bidirectional transcription. To do this,
we selected a 271bp fragment from the BUB1B
promoter that contains two functional SBS associated to
the RRACTACAN motif that was identiﬁed in our
previous studies (16). HeLa cells were transiently trans-
fected with constructs containing wt or mutant versions
of the BUB1B promoter fragment inserted into a dual
luciferase reporter vector. Figure 4 shows that the wt
fragment actually possessed bidirectional promoter
activity. However, the simultaneous mutations of the
two RRACTACAN and SBS motifs disabled completely
the promoter, demonstrating that the bidirectional activity
is directly due to the presence of the SBS and/or associated
RRACTACAN motifs (Figure 4). The bidirectional
activity dropped  14-fold following the simultaneous
mutation of the two SBS whereas that of both RRACT
ACAN motifs led to a 2-fold reduction (Figure 4). Lastly,
we tested the transcription capacity of a construct contain-
ing only one SBS without the associated RRACTACAN
motif. Figure 4 shows that the presence of the sole SBS
motif is sufﬁcient for bidirectional activity. These results
establish without ambiguity that the SBS is an element
with sufﬁcient intrinsic ability to direct efﬁcient transcrip-
tion activity in the direct and reverse orientations.
Knock-down and overexpression of hStaf/ZNF143 altered
expression from bidirectional gene pairs
Finally, we wished to examine the functional importance
of hStaf/ZNF143 in controling the expression of gene
pairs in vivo. To this end, we ﬁrst measured the abundance
of the corresponding mRNAs in HeLa cells in which ex-
pression of hStaf/ZNF143 was knocked-down by RNAi.
Cells were treated with a mixture of siRNAs and the
actual reduction of the hStaf/ZNF143 protein level was
monitored by western blot. A decrease of >80% of
hStaf/ZNF143 was obtained 72h post-transfection; this
Nucleic Acids Research,2011, Vol.39, No. 8 3123effect was speciﬁc because no change was observed with
siRNA-control treated cells (Figure 5A). The hStaf/
ZNF143 mRNA level also dropped speciﬁcally to >85%
in siRNA-treated cells (Figure 5B). The steady-state level
of mRNAs produced by expression of the 10 gene pairs
C11orf10–FEN1, KNTC1–RSRC2, C14orf133–AHSA1,
TMEM186–PMM2, TRAK2–STRADB, ZMAT5–
UCRC COL4A3BP–POLK, DOCK4–ZNF277,
NUDCD1–ENY2 and ZNF189–MRPL50 was measured
by RT–qPCR in 72h treated cells (Figure 5C). The bidir-
ectional promoters in these gene pairs are contacted by
hStaf/ZNF143 in vivo and gene expression was dependent
on SBS integrity in transient transfection assays. Four in-
dependent RNAi experiments indicated that the mRNA
levels obtained from the 10 gene pairs decreased between
63 and 97% in hStaf/ZNF143-depleted cells versus
non-depleted cells (Figure 5C).
Next, we tested the effect of hStaf/ZNF143
overexpression on the mRNA level of the same gene
pair set. Forty-eight hours after transfection of the recom-
binant vector expressing hStaf/ZNF143, we detected an
 2.5- and 1.8-fold increase of the hStaf/ZNF143 and
hStaf/ZNF143 mRNA levels, respectively (Figure 5A
and B). By measuring the mRNA content arising from
19 genes from 10 gene pairs in hStaf/ZNF143
overexpressing cells, we found a signiﬁcant increase
(1.2–2.75-fold) in the level of a vast majoriry of the
genes (18/19: 94%) (Figure 5C).
We conclude from these experiments that (i) variation in
the mRNA levels from all the analyzed genes, following
hStaf/ZNF143 depletion or overexpression, is consistent
with the data obtained from in vivo functional assays
(ChIP and luciferase assays); (ii) hStaf/ZNF143 positively
controls expression of divergent gene pairs.
DISCUSSION
In this article, with a higher quality data set of bidirec-
tional promoters that we extracted from the human
genome, we hightlighted new characteristics of this par-
ticular promoter class and their associated genes. A bias
toward the small size of genes associated to bidirectional
promoters versus unidirectional promoters, and another
one concerning the small size of bidirectional promoters
were evidenced. It should be mentionned here that the
peaks observed in the length distribution of the bidirec-
tional promoters are correlated to the span of DNA
wrapped around 1, 2 and 3 nucleosomes (one nucleosome
spans 147bp of DNA). Furthermore, by a genome scale
analysis we have (i) demonstrated that the hStaf/ZNF143
binding sites are overrepresented in bidirectional pro-
moters; (ii) deﬁned the functional signiﬁcance of its
firefly Renilla
SBS2
RRACTACAN wt-SBS wt
RRACTACAN mut-SBS wt
RRACTACAN wt-SBS mut
Renilla fold activation
SBS1
RRACTACAN wt
          SBS wt
RRACTACAN mut
            SBS wt
RRACTACAN wt
        SBS mut
RRACTACAN wt
          SBS wt
RRACTACAN mut
            SBS wt
RRACTACAN wt
        SBS mut
RRACTACAN mut
           SBS wt
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RRACTACAN mut-SBS mut
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9,4 x
5 x
2,8 x
0,7 x
18,6 x
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1,2 x
Figure 4. The staf binding site (SBS) bears the capacity to direct bidirectional transcription. Schematic diagrams of the reporter genes used in
transfection assays and dual luciferase activities. The BUB1B promoter fragment  464/ 194 (relative to the translation initiation codon) containing
two SBS (SBS1 and SBS2) and two RRACTACAN motifs was inserted into the dual luciferase vector. Boxed are RRACTACAN (light gray) and
SBS (solid box) elements. mut RRACTACAN (open box) and mut SBS (open box) constructs contain ACTAC to TATGG and CCCA to TTTC
substitutions, respectively. The relative transcription activities of the different constructs are indicated, representing the ﬁreﬂy and Renilla luciferase
activity/empty vector ratios. Values are mean±SE (error bars), n=3 independent experiments with two replicates/group.
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pairs. Our ﬁndings that hStaf/ZNF143 binds to at least
47% of the bidirectional promoters in the human genome,
and that hStaf/ZNF143 Binding Sites (SBS) are 2.4-fold
overrepresented in these promoters compared to unidirec-
tional ones, constitute strong evidence that hStaf/ZNF143
is an essential regulator of bidirectional transcription.
Direct experimental validation by ChIP on 87 promoters
of protein coding gene pairs (c–c) yielded 97% success,
indicating that very few of the identiﬁed sites were false
positives. Importantly, the high rate of success demon-
strates the robustness of the bioinformatic screen using
the PSSM established from a pool of 347 SBS that were
previously experimentally validated (18). Surprisingly, an
equivalent percentage of hStaf/ZNF143 binding was not
observed with the promoters of c–nc and nc–nc genes
pairs. Among the 13 tested promoters, only nine c-nc
gene pairs (69%) provided positive ampliﬁcation by
ChIP experiments. A possible explanation might be that
the identiﬁed SBS were located downstream of several of
the ncRNA genes. Indeed, the window used for the bio-
informatic screen covering the intergene and the ﬁrst
400bp downstream of the TSS, it could have encompassed
in several cases a ncRNA gene which is of small size
compared to a protein coding gene. This suggests that
the presence of the SBS per se is not sufﬁcient to recruit
hStaf/ZNF143 but that the binding requires a motif
located in the context of the gene promoter. Five of the
B relative hStaf/ZNF143 mRNA quantification
             RNAi hStaf/ZNF143
 0                              0.05                          0.1                          
A
C
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Figure 5. Effects of the hStaf/ZNF143 knock-down and overexpression on the mRNA level produced by divergent gene pairs. (A) hStaf/ZNF143
protein was knocked-down in HeLa cells by RNAi. Cells, either treated with RNAi control or treated with hStaf/ZNF143 siRNAs were harvested
72h after transfection. hStaf/ZNF143 protein overexpression was obtained by transfecting HeLa cells with a DNA construct containing the hStaf/
ZNF143 cDNA under the control of the CMV promoter. Total cellular protein were subjected to western blotting with polyclonal antibodies against
a C-terminal epitope of hStaf/ZNF143 or anti-AspRS as the internal control. (B) Total RNA was extracted from 72h treated and control cells, and
relative quantiﬁcation of hStaf/ZNF143 mRNA was carried out by quantitative RT–PCR. The bar indicated the relative content of mRNA
normalized to U3 snoRNA (endogenous control) in treated with respect to control cells, ﬁxed as 1. Values are expressed as a ratio and results
are mean±SD (n=8). Statistical analysis was performed using paired two-tailed Student’s t-test. (C) Relative mRNA quantiﬁcation by quantitative
RT-PCR in 10 divergent gene pairs. The measures were performed for one of the partners only in the two gene pairs C14orf133–AHSA1 and
DOCK4–ZNF277. The undetermined partner is marked as nd, not determined. Values are expressed as in (B).
Nucleic Acids Research,2011, Vol.39, No. 8 3125nine c–nc bidirectional promoters containing hStaf/
ZNF143 were shown to associate a protein coding gene
with a tRNA gene (LTA4H-tRNA
Asp-GTC, PRMT5-
tRNA
Arg-ACG, POLG-tRNA
Arg-TCG, PSMB3-
tRNA
AsnGTT, SLC27A4-tRNA
Arg-TCT). This suggests a
possible involvement of hStaf/ZNF143 in the transcrip-
tion of these tRNA genes by RNA polymerase III. In
the other four identiﬁed c-nc gene pairs, the ncRNA
partner is either RPPH1 (the RNase P RNA), the
SRP-RNA (RNA 7SL1) or a U6 snRNA gene. The
presence of a bidirectional promoter connecting the
RPPH1 and PARP2 mouse genes was previously
described but without establishing the involvement of
hStaf/ZNF143 in the control of gene expression (24).
Concerning the SRP–RNA, this is the ﬁrst report which,
to our knowledge, described that the SRP RNA (RNA
7SL1) and RPS29 genes share the same promoter bound
to the hSTAF/ZNF143 factor. In the human genome, ﬁve
functional U6 snRNA genes have been identiﬁed (25) and
we showed here that the U6.2 and U6.9 genes are
associated to a protein coding gene (C19orf6–
snRNAU6.2 and MED16–snRNAU6.9) in a bidirectional
promoter containing two functional SBS. We had previ-
ously demonstrated that RNA polymerase III transcrip-
tion of the human U6.1 gene requires Staf, and that the
transcriptional activation is performed via a single SBS
(9,26). In the case of the bidirectional promoters, the
mutation of either of the two SBS caused a reduction of
the transcription activity in the direction of the protein
gene. This result was expected as is the simultaneous
mutation of each SBS which reduced transcription
activity in both directions. However, and much to our
surprise, the mutation of one single SBS, whatever it
was, led to enhanced U6 expression. This surprising
result must be examined in the context of the snRNA
gene promoter architecture. In fact, all the snRNA gene
promoters characterized so far contain only one single
SBS (26) and our report is the ﬁrst describing the
presence of two SBS in the promoter of an snRNA
gene. In the light of our data, it looks as if the presence
of two SBS is incompatible with the optimal formation of
transcription complexes and is detrimental to U6
expression.
Our bioinformatic screen showed that 21% of the
identiﬁed SBS were associated with the 9bp functional
RRACTACAN motif. The transcription level of con-
structs containing only the RRACTACAN motif is very
low. Paradoxically, mutation of the RRACTACAN motif
in the presence of a wt SBS yielded a 50% drop of tran-
scription efﬁciency, suggesting an important role of this
motif, but only in the context of the SBS. It may well be
that this motif serves as a binding site for an unknown
transcription factor. It might also induce a particular
DNA local structure enhancing the afﬁnity of hStaf/
ZNF143 to its cognate sequence. The RRACTACAN
sequence is particulary interesting in the light of the
work describing the discovery of motifs overrepresented
in human bidirectional promoters (6). This analysis
yielded ﬁve motifs, including the NRF-1, GABPA, YY1
and NFY transcription factor binding sites, and the ﬁfth
one of sequence ACTACANNTCCC with no known
identiﬁed transcription factor. It was predicted that the
ACTACANNTCCC sequence and the cognate transcrip-
tion factor would play an important role in regulating
bidirectional transcription. Our work established clearly
that ACTACAN indeed corresponds to the 30-part of
the RRACTACAN motif that we identiﬁed and that
NTCCC represents SBS residues 1–5. Lin et al. (6) did
not report residues 6–18 of the SBS as overrepresented
in bidirectional promoters. This is very likely because of
the lower sequence conservation in this part of the SBS. A
similar motif with the ACTAYRNNNCCCR consensus
sequence was previously reported by Xie et al. (27) who
ranked it fourth among 174 motifs in terms of conserva-
tion across several mammalian transcription factors. In
the present work, we showed that a signiﬁcant part
(20%) of the identiﬁed SBS is linked to the RRACTAC
AN motif. If this motif is the target for an unknown tran-
scription factor, we propose that this factor is also an es-
sential actor working in conjunction with hStaf/ZNF143
to regulate bidirectional transcription.
Finally, we have also demonstrated that insertion of the
unidirectional BUB1B promoter [containing functional
SBS (16)] into the dual luciferase reporter was sufﬁcient
to induce bidirectional transcription. The observation that
a unidirectional promoter can drive transcription in two
opposite directions should be examined in the light of
recent data which collectively established that promoters
can support divergent initiation of transcription but pro-
ductive elongation occurs only in the direction of the genes
(28–34). In an earlier work, we had demonstrated that
hStaf/ZNF143 binds to and controls expression from a
large number of unidirectional promoters (18). The
presence of a single SBS is sufﬁcient to direct bidirectional
activity and this intrinsic ability of hStaf/ZNF143 suggests
that hStaf/ZNF143 can be involved in divergent transcrip-
tion from unidirectional promoters (28–34). The transcrip-
tion factor GABPA/NRF2 (7) also bears the capacity to
direct bidirectional transcription and, to our knowledge,
hStaf/ZNF143 and GABPA/NRF2 are the two sole
factors described so far with this particular ability.
In conclusion, we have shown that hStaf/ZNF143 binds
to and governs expression from a majority of bidirectional
promoters. The picture emerging from our current and
previous studies strengthens the role of hStaf/ZNF143 as
an essential factor for controling gene expression in
humans.
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